-
The Mesothelioma Registry is Crucial for Timely Diagnosis and Treatment of Oswego County Veterans
23 Oct 2025 15:17 GMT
… a well-established connection between mesothelioma and asbestos exposure, currently, …
Misdiagnosis Delays Mesothelioma Treatment and Costs Lives
Mesothelioma’s rarity makes … Oswego County
Firstly, a mesothelioma registry would significantly improve diagnostic …
-
University of Hawai‘i Cancer Center identifies treatable form of mesothelioma
22 Oct 2025 21:07 GMT
… less aggressive form of mesothelioma that offers patients greater … , internationally recognized leaders in mesothelioma research, the team’s … called low-grade BAP1-associated mesothelioma (L-BAM), stems from … now have new hope.”
Mesothelioma is a rare cancer …
-
AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
22 Oct 2025 16:00 GMT
… in a human epithelioid mesothelioma cell line, associated with … an immunocompetent in vivo mesothelioma model, TT-4 monotherapy … Title: ADORA2B inhibition in Mesothelioma (MMe) cells affects PD … an initial focus on mesothelioma, advancing toward first-patient …
-
Jury awards $13.5M to family of Cowlitz County worker who died of mesothelioma
22 Oct 2025 14:22 GMT
… worker who died from mesothelioma caused by asbestos exposure … Conner was diagnosed with mesothelioma in December 2023 and … exposure, which can cause mesothelioma after only a few … Although short exposures can cause mesothelioma, symptoms may not appear …
-
VT3989 shows promising antitumor activity in refractory mesothelioma patients
22 Oct 2025 12:39 GMT
… , particularly in patients with refractory mesothelioma, according to results from a … 135 with refractory mesothelioma. Of the 22 mesothelioma patients treated with the … loss are common in mesothelioma patients.
Additionally, mesothelioma is a cancer that …
-
<![CDATA[Imfinzi With Chemo Produces Inconclusive Outcomes in Phase 3 Mesothelioma Study]]>
19 Oct 2025 20:04 GMT
… among patients with advanced pleural mesothelioma, echoing findings from earlier … enrolled patients with advanced pleural mesothelioma and patient enrollment began … ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, …
-
<![CDATA[Durvalumab/Chemotherapy Prove Inconclusive in Phase 3 for Mesothelioma]]>
19 Oct 2025 19:43 GMT
… president-elect of the International Mesothelioma Interest Group.
REFERENCES:
1. … line treatment in advanced pleural Mesothelioma – A phase 3 Randomised … ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised …
-
ESMO 2025: VT3989 Continues to Show Promising Early Results in Patients with Advanced Mesothelioma
19 Oct 2025 18:44 GMT
… , particularly in patients with refractory mesothelioma, according to results from a … 135 with refractory mesothelioma. Of the 22 mesothelioma patients treated with the … loss are common in mesothelioma patients.
Additionally, mesothelioma is a cancer that …
-
VT3989, Vivace Therapeutics' Best-in-Class, Hippo Pathway-Targeting Therapy, Demonstrates Promising Antitumor Activity in Refractory Mesothelioma
19 Oct 2025 17:04 GMT
… solid tumors, including refractory mesothelioma. The mesothelioma patients treated with the … Administration for the treatment of mesothelioma. The Fast Track Designation … promising-antitumor-activity-in-refractory-mesothelioma-302588304.html
SOURCE Vivace …
-
ESMO 2025: VT3989 Demonstrates Promising Early Outcomes in Advanced Mesothelioma Patients
19 Oct 2025 16:41 GMT
… for notoriously resistant cancers.
Mesothelioma, an aggressive malignancy … , Solid tumors, Mesothelioma
Tags: advanced mesothelioma treatmentasbestos-related lung … II clinical trial studyrefractory mesothelioma researchtargeted therapies for cancerVT3989 …
About
© 1995-2025